BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 1319, American Rescue Plan Act of 2021 - regarding all bio-pharmaceutical related provisions H.R. 2630/S.464, Safe Step Act - regarding all bio-pharmaceutical related provisions Discussions regarding health equity End of year health package/PBM reform H.R.485, Protecting Health Care for All Patients of 2023 Act H.R.830, HELP Copays Act of 2023 Discussions in support of H.R.5376, Share the Savings with Seniors Act Discussions in support of H.R.5539, ORPHAN Cures Act H.R.3561, The PATIENT Act H.R.4895, Lowering Drug Costs for American Families Act Discussions in support of H.R.2880, Protecting Patients Against PBM Abuses Act H.R.2408, Access to Innovative Treatments Act of 2023
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BRUNET | — |
| JOHN DEOUDES | — |
| STEPHANIE A. DYSON | — |
| KATHRYN NOVARIA | — |
| LANE PENRY | — |
| CAROLINE TUCKER | — |
| PAUL ANTHONY WILLIAMS | — |
Medicare/Medicaid MMM
Issues related to the 340B Drug Pricing Program - regarding all bio-pharmaceutical related provisions Inflation Reduction Act implementation
| Lobbyist | Covered position, as disclosed |
|---|---|
| LANE PENRY | — |
| PAUL ANTHONY WILLIAMS | — |
Taxation/Internal Revenue Code TAX
Proposed policies regarding corporate tax reform - regarding all bio-pharmaceutical related provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BRUNET | — |
| JOHN DEOUDES | — |
Budget/Appropriations BUD
Discussions regarding H.R.6363, making further continuing appropriations for FY2024
| Lobbyist | Covered position, as disclosed |
|---|---|
| LANE PENRY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.